Jesper Vallentin Kjerulff

Jesper Vallentin Kjerulff has a diverse work experience spanning over several years. Jesper Vallentin is currently serving as the Chief Operating Officer at PharmNovo since 2023. Previously, they worked as the Global Program Leader at oncoteq AG from 2022 to 2023. Prior to that, they held the role of Global Project Lead at PharmNovo from 2021 to 2022.

In 2020, Jesper worked as a Project Director at KLIFO A/S. Jesper Vallentin also has extensive experience at Lundbeck, where they held various roles. Jesper Vallentin served as the Chief Project Director from 2015 to 2020, leading global projects and teams. Jesper Vallentin was responsible for the development of small molecules and biologics, including successful product launches such as Brintellix®.

Before joining Lundbeck, Jesper's career began at the Danish Patent and Trademark Office, where they served as the Head of Division from 2000 to 2002. Jesper Vallentin was responsible for the patent division and oversaw the examination of patent applications in the biotechnology, pharmaceuticals, food, and agriculture sectors.

Earlier in their career, they worked as a Project Manager at Novozymes, where they led various projects at the enzyme division. Jesper Vallentin was involved in the development and launch of DeniLite® and contributed to several patent applications related to enzyme technologies.

Jesper's work experience also includes a role as a Lecturer at The Scandinavian School of Brewing from 1991 to 1993.

Overall, Jesper Vallentin Kjerulff has held strategic and leadership positions in the pharmaceutical, biotechnology, and brewing industries, demonstrating a strong track record of successful project management and cross-functional collaboration.

Jesper Vallentin Kjerulff has a diverse educational background. Jesper Vallentin began their education at Sankt Joergens Gymnasium, where they studied Mathematics and Physics in high school from 1980 to 1983. Following this, they attended DTU - Technical University of Denmark from 1989 to 1991, completing a PhD in Biotechnology. During this time, in 1990-1991, they also conducted research at Institut Pasteur in Paris, focusing on Mammalian Cell Culture and obtaining a PhD degree. Jesper then pursued further studies at Copenhagen Business School from 1992 to 1995, earning an HD (BCom) in Udenrigshandel (International Trade).

In 1983, Jesper Vallentin Kjerulff enrolled at DTU - Technical University of Denmark once again, but this time for a master's degree. Jesper Vallentin completed their MSc in Chemical and Biotechnology from 1983 to 1989. Continuing their education in a different field, Jesper attended the University of Basel from 2003 to 2005, where they obtained a Diploma of Advanced Studies in Pharmaceutical Medicine, focusing on Pharmaceutical Development.

Lastly, in 2001, Jesper Vallentin Kjerulff attended the Danish Institute for IPR Training (DIFI) for a brief period of time, studying IP Law, Business Law, and IP Agreements. No specific degree was mentioned for this educational experience.